Skip to main content
Equibles

UBS Group AG

Position in IMMX — Immix Biopharma, Inc.

CIK 1610520 ZURICH, V8
Back to IMMX Full portfolio

Position in IMMX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,020,132
+$19,320,193 QoQ
Shares Held
1,941,817
+2427.4% QoQ
Ownership
2.71%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 109 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. IMMX ranks #83 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in IMMX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,020,132 1,941,817
2026-03-31 $699,939 76,832
2025-12-31 $306,472 58,599
2025-09-30 $4,054 1,940
2025-06-30 $28,921 13,972
2025-03-31 $17,002 10,121
2024-12-31 $31,257 14,208
2024-09-30 $9,157 6,146
2024-06-30 $6,244 3,154
2024-03-31 $16,142 5,258
2023-12-31 $18,185 2,628
2023-03-31 $4,187 2,301
2022-12-31 $10,733 4,687
2022-09-30 $16,325 12,004
2022-06-30 $11,276 4,337
2021-12-31 $116,230 32,649